<DOC>
	<DOC>NCT00822874</DOC>
	<brief_summary>A single centre randomised controlled trial investigating the influence of a novel prematuration system (PMS) using a phosphodiesterase-3 inhibitor for in-vitro maturation of oocytes - pilot study.</brief_summary>
	<brief_title>Influence of a Prematuration Culture With a Phosphodiesterase-3 Inhibitor (PDE3-I) on Embryonic Aneuploidy Rate and Developmental Potential</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Aneuploidy</mesh_term>
	<mesh_term>Phosphodiesterase 3 Inhibitors</mesh_term>
	<criteria>healthy volunteers, either with PCOS/PCOSlike ovaries, or with normal ovaries, who undergo oocyte donation for research AFC at least 10 AMH: &gt; 5 Î¼g/L Female age &lt; 36 years major uterine or ovarian abnormalities</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>PCOS and normal ovulatory patients</keyword>
	<keyword>aneuploidy</keyword>
	<keyword>in-vitro maturation of oocytes</keyword>
</DOC>